Clearance of HCV RNA with valopicitabine (NM283) plus peg-interferon in treatment-naive patients with HCV-1 infection: Results at 24 and 48 weeks

被引：26

作者：

Lawitz, E.

Nguyen, T.

Younes, Z.

Santoro, J.

Gitlin, N.

McEniry, D.

Chasen, R.

Goff, J.

Dieterich, D.

Knox, S.

Kleber, K.

Belanger, B.

Brown, N. A.

Grp, Investigator

机构：

[1] Alamo Med Res, San Antonio, TX USA

[2] Gastroenterol Ctr Mid S, Germantown, TN USA

[3] AGA Clin Res Assoc, Egg Harbor, NJ USA

[4] Emory Univ, Atlanta Gastroenterol Associates, Atlanta, GA 30322 USA

[5] NW Med Specialties, Tacoma, WA USA

[6] Maryland Digest Dis Res, Laurel, MD USA

[7] Rocky Mt Gastroenterol, Lakewood, CO USA

[8] Mt Sinai Sch Med, New York, NY USA

[9] Idenix Pharmaceut, Cambridge, MA USA

来源：

关键词：

D O I：

10.1016/S0168-8278(07)61612-2

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：S9 / S9

页数：1